Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.2850
+0.0050 (1.79%)
At close: Feb 27, 2026
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of CAD 75.53 million as of March 2, 2026. Its market cap has increased by 17.24% in one year.
Market Cap
75.53M
Enterprise Value
75.76M
Revenue
1.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
Market Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 75.53M, an increase of 806.93%. That is a compound annual growth rate of 7.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 75.53M | 72.79% |
| Dec 31, 2025 | 43.71M | -33.43% |
| Dec 31, 2024 | 65.66M | 64.23% |
| Dec 28, 2023 | 39.98M | -42.29% |
| Dec 30, 2022 | 69.28M | -9.56% |
| Dec 31, 2021 | 76.60M | 97.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 374.91M |
| Cannabix Technologies | 68.59M |
| Perimeter Medical Imaging AI | 36.71M |
| Conavi Medical | 36.71M |
| Cheelcare | 35.37M |
| Aurora Spine | 20.52M |
| Ventripoint Diagnostics | 19.60M |
| MedX Health | 18.04M |